883.85
1.44%
12.53
Handel nachbörslich:
883.13
-0.72
-0.08%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NFLX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$871.32
Offen:
$879.98
24-Stunden-Volumen:
4.00M
Relative Volume:
1.34
Marktkapitalisierung:
$375.55B
Einnahmen:
$37.59B
Nettoeinkommen (Verlust:
$7.78B
KGV:
88.21
EPS:
10.02
Netto-Cashflow:
$7.12B
1W Leistung:
+6.43%
1M Leistung:
+15.70%
6M Leistung:
+37.92%
1J Leistung:
+86.28%
Netflix Inc Stock (NFLX) Company Profile
Firmenname
Netflix Inc
Sektor
Branche
Telefon
408-540-3700
Adresse
121 ALBRIGHT WAY, LOS GATOS
Vergleichen Sie NFLX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
NFLX | 883.85 | 375.55B | 37.59B | 7.78B | 7.12B | 10.02 |
DIS | 114.26 | 203.74B | 91.36B | 4.97B | 8.56B | 1.23 |
LYV | 136.51 | 31.16B | 23.32B | 476.50M | 662.36M | 1.42 |
WBD | 9.95 | 24.52B | 39.58B | -11.22B | 5.31B | -2.72 |
FWONK | 84.07 | 20.91B | 3.69B | 279.00M | 426.00M | 1.88 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-10-18 | Bestätigt | Needham | Buy |
2024-10-18 | Bestätigt | Oppenheimer | Outperform |
2024-10-18 | Bestätigt | Pivotal Research Group | Buy |
2024-10-16 | Bestätigt | Loop Capital | Buy |
2024-10-11 | Bestätigt | Guggenheim | Buy |
2024-10-10 | Bestätigt | Morgan Stanley | Overweight |
2024-10-10 | Bestätigt | Oppenheimer | Outperform |
2024-10-07 | Herabstufung | Barclays | Equal Weight → Underweight |
2024-10-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
2024-10-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-09-05 | Eingeleitet | China Renaissance | Hold |
2024-08-30 | Bestätigt | Pivotal Research Group | Buy |
2024-07-17 | Bestätigt | Guggenheim | Buy |
2024-07-16 | Bestätigt | The Benchmark Company | Sell |
2024-07-15 | Bestätigt | BofA Securities | Buy |
2024-07-12 | Bestätigt | JP Morgan | Overweight |
2024-07-10 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-07-09 | Bestätigt | TD Cowen | Buy |
2024-07-02 | Bestätigt | Argus | Buy |
2024-05-28 | Bestätigt | Evercore ISI | Outperform |
2024-04-19 | Herabstufung | Canaccord Genuity | Buy → Hold |
2024-04-19 | Hochstufung | Needham | Hold → Buy |
2024-04-19 | Bestätigt | Pivotal Research Group | Buy |
2024-04-15 | Bestätigt | Deutsche Bank | Hold |
2024-04-12 | Bestätigt | Morgan Stanley | Overweight |
2024-04-12 | Bestätigt | Piper Sandler | Neutral |
2024-04-05 | Bestätigt | Pivotal Research Group | Buy |
2024-03-25 | Bestätigt | Citigroup | Neutral |
2024-03-12 | Bestätigt | Jefferies | Buy |
2024-03-11 | Bestätigt | Oppenheimer | Outperform |
2024-01-30 | Herabstufung | Seaport Research Partners | Buy → Neutral |
2024-01-25 | Hochstufung | DZ Bank | Hold → Buy |
2024-01-24 | Bestätigt | BMO Capital Markets | Outperform |
2024-01-24 | Bestätigt | BofA Securities | Buy |
2024-01-24 | Bestätigt | Canaccord Genuity | Buy |
2024-01-24 | Bestätigt | Evercore ISI | Outperform |
2024-01-24 | Bestätigt | Goldman | Neutral |
2024-01-24 | Bestätigt | Guggenheim | Buy |
2024-01-24 | Bestätigt | JP Morgan | Overweight |
2024-01-24 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-01-24 | Hochstufung | Macquarie | Neutral → Outperform |
2024-01-24 | Bestätigt | Morgan Stanley | Overweight |
2024-01-24 | Bestätigt | Oppenheimer | Outperform |
2024-01-24 | Bestätigt | Piper Sandler | Neutral |
2024-01-24 | Bestätigt | Pivotal Research Group | Buy |
2024-01-24 | Bestätigt | Redburn Atlantic | Buy |
2024-01-24 | Bestätigt | Robert W. Baird | Outperform |
2024-01-24 | Bestätigt | TD Cowen | Outperform |
2024-01-24 | Bestätigt | UBS | Buy |
2024-01-24 | Bestätigt | Wells Fargo | Overweight |
2023-09-18 | Bestätigt | Evercore ISI | Outperform |
2023-08-25 | Hochstufung | Loop Capital | Hold → Buy |
2023-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2023-07-17 | Bestätigt | Deutsche Bank | Buy |
2023-07-13 | Bestätigt | JP Morgan | Overweight |
2023-07-12 | Bestätigt | UBS | Buy |
2023-07-05 | Hochstufung | Goldman | Sell → Neutral |
2023-06-29 | Bestätigt | Citigroup | Buy |
2023-06-28 | Bestätigt | Oppenheimer | Outperform |
2023-06-13 | Bestätigt | BofA Securities | Buy |
2023-06-13 | Bestätigt | Guggenheim | Buy |
2023-04-19 | Bestätigt | Deutsche Bank | Buy |
2023-04-19 | Bestätigt | JP Morgan | Overweight |
2023-04-19 | Bestätigt | Jefferies | Buy |
2023-04-19 | Bestätigt | Piper Sandler | Neutral |
2023-04-19 | Bestätigt | Pivotal Research Group | Buy |
2023-04-19 | Bestätigt | Rosenblatt | Neutral |
2023-04-19 | Hochstufung | UBS | Neutral → Buy |
2023-04-11 | Fortgesetzt | Robert W. Baird | Neutral |
2023-01-23 | Bestätigt | Argus | Buy |
2023-01-20 | Bestätigt | Canaccord Genuity | Buy |
2023-01-20 | Bestätigt | Deutsche Bank | Buy |
2023-01-20 | Bestätigt | Evercore ISI | Outperform |
2023-01-20 | Bestätigt | Goldman | Sell |
2023-01-20 | Bestätigt | Guggenheim | Buy |
2023-01-20 | Bestätigt | Jefferies | Buy |
2023-01-20 | Bestätigt | MoffettNathanson | Market Perform |
2023-01-20 | Bestätigt | Oppenheimer | Outperform |
2023-01-20 | Bestätigt | Piper Sandler | Neutral |
2023-01-20 | Bestätigt | Pivotal Research Group | Buy |
2023-01-20 | Bestätigt | Robert W. Baird | Neutral |
2023-01-20 | Bestätigt | The Benchmark Company | Sell |
2023-01-20 | Bestätigt | Wedbush | Outperform |
2023-01-20 | Bestätigt | Wolfe Research | Outperform |
2023-01-12 | Hochstufung | Jefferies | Hold → Buy |
2023-01-04 | Eingeleitet | New Street | Neutral |
2022-12-29 | Hochstufung | CFRA | Sell → Buy |
2022-12-14 | Bestätigt | Jefferies | Hold |
2022-12-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2022-06-14 | Herabstufung | The Benchmark Company | Hold → Sell |
2022-06-10 | Herabstufung | Goldman | Neutral → Sell |
2022-05-16 | Hochstufung | Wedbush | Neutral → Outperform |
2022-04-21 | Herabstufung | DZ Bank | Buy → Hold |
2022-04-21 | Herabstufung | Edward Jones | Buy → Hold |
2022-04-20 | Herabstufung | Atlantic Equities | Overweight → Neutral |
2022-04-20 | Herabstufung | BofA Securities | Buy → Underperform |
2022-04-20 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-04-20 | Hochstufung | Needham | Underperform → Hold |
2022-04-20 | Herabstufung | Oppenheimer | Outperform → Perform |
2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
2022-04-20 | Herabstufung | Pivotal Research Group | Buy → Sell |
2022-04-20 | Herabstufung | Stifel | Buy → Hold |
2022-04-20 | Herabstufung | UBS | Buy → Neutral |
2022-04-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-04-19 | Eingeleitet | Rosenblatt | Neutral |
2022-03-09 | Hochstufung | Wedbush | Underperform → Neutral |
2022-01-31 | Hochstufung | Citigroup | Neutral → Buy |
2022-01-31 | Hochstufung | Edward Jones | Hold → Buy |
2022-01-24 | Herabstufung | Jefferies | Buy → Hold |
2022-01-21 | Bestätigt | BMO Capital Markets | Outperform |
2022-01-21 | Bestätigt | BofA Securities | Buy |
2022-01-21 | Bestätigt | Canaccord Genuity | Buy |
2022-01-21 | Bestätigt | Cowen | Outperform |
2022-01-21 | Bestätigt | Deutsche Bank | Hold |
2022-01-21 | Bestätigt | Goldman | Neutral |
2022-01-21 | Bestätigt | Guggenheim | Buy |
2022-01-21 | Bestätigt | JP Morgan | Overweight |
2022-01-21 | Bestätigt | MoffettNathanson | Neutral |
2022-01-21 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
2022-01-21 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2022-01-21 | Bestätigt | Oppenheimer | Outperform |
2022-01-21 | Bestätigt | Piper Sandler | Overweight |
2022-01-21 | Bestätigt | Pivotal Research Group | Buy |
2022-01-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2022-01-21 | Bestätigt | Stifel | Buy |
2022-01-21 | Hochstufung | The Benchmark Company | Sell → Hold |
2022-01-21 | Herabstufung | Truist | Buy → Hold |
2022-01-21 | Bestätigt | UBS | Buy |
2022-01-21 | Bestätigt | Wolfe Research | Outperform |
2021-12-15 | Bestätigt | The Benchmark Company | Sell |
2021-10-20 | Herabstufung | Deutsche Bank | Buy → Hold |
2021-10-20 | Bestätigt | Monness Crespi & Hardt | Buy |
2021-09-29 | Bestätigt | The Benchmark Company | Sell |
2021-09-13 | Eingeleitet | Goldman | Neutral |
2021-09-08 | Bestätigt | JP Morgan | Overweight |
2021-09-07 | Bestätigt | Atlantic Equities | Overweight |
2021-07-21 | Bestätigt | Credit Suisse | Outperform |
2021-07-21 | Bestätigt | Deutsche Bank | Buy |
2021-07-21 | Bestätigt | JP Morgan | Overweight |
2021-07-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
2021-07-21 | Bestätigt | Stifel | Buy |
2021-06-25 | Hochstufung | Credit Suisse | Neutral → Outperform |
2021-06-25 | Eingeleitet | Edward Jones | Hold |
2021-05-19 | Fortgesetzt | Jefferies | Buy |
2021-04-21 | Fortgesetzt | Oppenheimer | Outperform |
2021-04-21 | Bestätigt | Pivotal Research Group | Buy |
2021-04-21 | Hochstufung | Stifel | Hold → Buy |
2021-04-06 | Fortgesetzt | Evercore ISI | Outperform |
2021-04-01 | Eingeleitet | Piper Sandler | Overweight |
2021-03-25 | Bestätigt | The Benchmark Company | Sell |
2021-03-23 | Hochstufung | Argus | Hold → Buy |
2021-01-21 | Hochstufung | DZ Bank | Hold → Buy |
2021-01-20 | Bestätigt | Monness Crespi & Hardt | Buy |
2021-01-20 | Bestätigt | Pivotal Research Group | Buy |
2021-01-20 | Bestätigt | The Benchmark Company | Sell |
2021-01-20 | Hochstufung | UBS | Neutral → Buy |
2021-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2020-10-21 | Bestätigt | BMO Capital Markets | Outperform |
2020-10-21 | Bestätigt | Bernstein | Outperform |
2020-10-21 | Bestätigt | Jefferies | Buy |
2020-10-21 | Bestätigt | Morgan Stanley | Overweight |
2020-10-21 | Bestätigt | Oppenheimer | Outperform |
2020-10-21 | Bestätigt | Piper Sandler | Overweight |
2020-10-21 | Bestätigt | Pivotal Research Group | Buy |
2020-10-21 | Bestätigt | RBC Capital Mkts | Outperform |
2020-10-21 | Bestätigt | The Benchmark Company | Sell |
2020-10-21 | Bestätigt | Wedbush | Underperform |
2020-10-21 | Bestätigt | Wells Fargo | Equal Weight |
2020-10-16 | Bestätigt | Morgan Stanley | Overweight |
2020-10-15 | Bestätigt | Canaccord Genuity | Buy |
2020-10-14 | Bestätigt | Goldman | Buy |
2020-10-07 | Bestätigt | Pivotal Research Group | Buy |
2020-09-28 | Bestätigt | The Benchmark Company | Sell |
2020-09-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2020-09-09 | Fortgesetzt | Raymond James | Mkt Perform |
2020-09-04 | Bestätigt | The Benchmark Company | Sell |
2020-07-29 | Bestätigt | Loop Capital | Buy |
Alle ansehen
Netflix Inc Aktie (NFLX) Neueste Nachrichten
A Man on the Inside review — Netflix comedy plants a spy in a retirement home - Financial Times
Director Anne Sweeney Sells 1,190 Shares of Netflix Inc (NFLX) - GuruFocus.com
Netflix Inc (NFLX) Director Leslie Kilgore Sells 940 Shares - GuruFocus.com
Netflix director Leslie Kilgore sells $819,323 in stock - Investing.com
Netflix director Anne Sweeney sells $1.04 million in stock - Investing.com
Netflix, Inc. (NASDAQ:NFLX) Director Sells $518,320.00 in Stock - MarketBeat
Netflix director Anne Sweeney sells $1.04 million in stock By Investing.com - Investing.com UK
Tampa attorney filing class-action lawsuit over failed Netflix stream of Jake Paul, Mike Tyson fight - FOX 13 Tampa
Netflix to Boost Production of Japanese Titles, as Subscribers Skyrocket in Asia - The Japan News
Netflix Inc. stock outperforms competitors on strong trading day - MSN
Netflix Sued Over Technical Glitches in ‘Unwatchable’ Jake Paul-Mike Tyson Boxing Match - Variety
'Squid Game' S2 & Everything Else Coming to Netflix in December - Teen Vogue
Netflix Hit With Class Action Lawsuit Over Streaming Issues on Jake Paul-Mike Tyson Bout - Hollywood Reporter
Netflix sued over Jake Paul and Mike Tyson fight - Daily Mail
Ol Parker Directing Jennifer Lopez & Brett Goldstein’s ‘Office Romance’ At Netflix - Deadline
Complaint filed against Netflix for streaming issues during Paul vs. Tyson fight - ABC Action News Tampa Bay
Netflix’s ‘Joy’ Is a Loud Cheer for Fertility, for Never Giving Up — and Science - KQED
Can Netflix’s stock hit $1,100? Wall Street’s biggest bull charts the path. - MSN
Netflix Faces Class-Action Lawsuit Over Streaming Crashes During Jake Paul, Mike Tyson Fight - Benzinga
Netflix price target lifted after Jake Paul, Mike Tyson fight - Yahoo Finance
Analyst revises Netflix stock price targetFinbold - Finbold - Finance in Bold
‘A Good Girl’s Guide to Murder’ Renewed for Season 2 at Netflix - Hollywood Reporter
Retireful LLC Takes Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Darwin Wealth Management LLC Reduces Holdings in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
1,650 Shares in Netflix, Inc. (NASDAQ:NFLX) Purchased by Bellwether Advisors LLC - MarketBeat
Pivotal Research Forecasts Strong Price Appreciation for Netflix (NASDAQ:NFLX) Stock - MarketBeat
EULAV Asset Management Lowers Holdings in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Athletic Brewing and Netflix Launch Marine Odyssey IPA - PR Newswire
Netflix target raised to new Street high at Pivotal Research - Investing.com
Netflix Stock Hits Record After Tyson vs. Paul. Why This Analyst Predicts a 26% Jump. - MSN
Netflix Inc. stock underperforms Thursday when compared to competitors despite daily gains - MSN
Netflix, Inc. (NASDAQ:NFLX) Shares Sold by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Research Reveals The Nations Most Enthralled By Netflix’s Tyson-Paul Fight - Deadline
Are streaming services ready to replace traditional broadcasters with live sports? - Sportcal
Netflix stock price target increased by 19%, analyst cites successful live events - Investing.com India
Jennison Associates LLC Has $4.96 Billion Holdings in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Sky TV Black Friday deals: how to save money and get free Netflix inc. Sky Sports, Cinema and Kids - What To Watch
Segall Bryant & Hamill LLC Invests $28.97 Million in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
PNC Financial Services Group Inc. Sells 4,068 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Banque Cantonale Vaudoise Cuts Stake in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix, Inc. (NASDAQ:NFLX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Netflix subscriber sues company for 'breach of contract' over poor quality of Mike Tyson-Jake Paul fight - Fox News
Boxing farce nets Netflix 108 million viewers and record share price - Proactive Investors Australia
Netflix Sued Over Alleged Backroom Deal With Meta to Stand Down on Streaming - Hollywood Reporter
Netflix Tyson-Paul fight livestream buckles under pressure - Axios
Report: Netflix Hosting Large Gathering Of WWE Wrestlers At Company HQ In December - Rajah.com
Netflix Stock Gets Price-Target Hikes On Live Sports Potential - Investor's Business Daily
Netflix stock hits record after reveal that Tyson-Paul had 108 million viewers - MarketWatch
Netflix Stock Hits All-Time High With Bump From Tyson-Paul Fight, Beyoncé - Investopedia
Netflix (NASDAQ:NFLX) Stock Price Up 0.6%Still a Buy? - MarketBeat
Mike Tyson, Jake Paul fight was the most-streamed sporting event ever, Netflix says - NBC DFW
Finanzdaten der Netflix Inc-Aktie (NFLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):